1,263 research outputs found

    Demonstration of a New Smallsat Launch Vehicle: The Orbital/Suborbital Program (OSP) Space Launch Vehicle Inaugural Mission Results

    Get PDF
    The United States Air Force and Orbital Sciences Corporation (Orbital) completed development and demonstration of a new low cost space launch vehicle for launching small satellites using surplus Minuteman II rocket motors melded with commercial launch vehicle technology. The Orbital Suborbital Program Space Launch Vehicle (OSPSLV, aka OSP Minotaur) successfully achieved all mission objectives with the inaugural launch into a 405 nm circular, 100 deg inclination orbit on 26 January, 2000. This launch achieved “firsts” in several areas including being the first space launch utilizing Minuteman boosters. It was also the first launch from the California Spaceport (Spaceport Systems International Commercial Launch Facility) at Vandenberg AFB. The OSP Minotaur accurately delivered a total of 11 satellites to orbit on its inaugural launch, involving complex maneuvering and multiple payload separations. Satellite sizes covered the range from minisatellite (JAWSAT Multiple Payload Adapter (MPA), 110 kg), microsatellite (USAFA’s FalconSat, 50 kg, and OPAL, 20kg), nanosatellite (Arizona State University’s ASUSat-1.5 kg), and picosatellites (ARPA/Aerospace, ARTEMIS, STENSAT, and MASAT, 0.5 kg each). ASUSat-1 was the first scientific nanosatellite and the picosats were the world’s first active “pico” satellites. Additionally, an Optical Calibration Sphere was placed into orbit for the Air Force Research Laboratory (AFRL) Starfire Optical Range. The mission also demonstrated the Soft Ride for Small Satellites (SRSS) full-spacecraft isolation system developed by AFRL and CSA Engineering. The OSP Minotaur is a four stage, ground launched solid propellant inertially guided spacelift vehicle. It is capable of putting up to 1400 lbm into LEO (100 nm, 28.5 deg) and over 700 lbm into a 400 nm, sunsynchronous orbit. The first two stages are from surplus Minuteman II ICBM’s (M-55 and SR-19). They are combined with the upper two stages (Orion 50XL and Orion 38), structure, and fairing from Orbital’s Pegasus XL air-launched space vehicle. However, new flight software, avionics, and telemetry components provide greater payload support capability relative to the Pegasus system

    The Lantern Vol. 14, No. 1, December 1945

    Get PDF
    • Editorial • The Medal • Pain • Wonder • Warmth • Memory Lingers • Morning • Watch the Birdie • Poems • The War Dogs of the Devildogs • Joy in Every Heart • To Live in Hearts • The Operation • Moderately Well Done • Steak is King • Grateful America?https://digitalcommons.ursinus.edu/lantern/1037/thumbnail.jp

    The Lantern Vol. 14, No. 1, December 1945

    Get PDF
    • Editorial • The Medal • Pain • Wonder • Warmth • Memory Lingers • Morning • Watch the Birdie • Poems • The War Dogs of the Devildogs • Joy in Every Heart • To Live in Hearts • The Operation • Moderately Well Done • Steak is King • Grateful America?https://digitalcommons.ursinus.edu/lantern/1037/thumbnail.jp

    Intelligence within BAOR and NATO's Northern Army Group

    Get PDF
    During the Cold War the UK's principal military role was its commitment to the North Atlantic Treaty Organisation (NATO) through the British Army of the Rhine (BAOR), together with wartime command of NATO's Northern Army Group. The possibility of a surprise attack by the numerically superior Warsaw Pact forces ensured that great importance was attached to intelligence, warning and rapid mobilisation. As yet we know very little about the intelligence dimension of BAOR and its interface with NATO allies. This article attempts to address these neglected issues, ending with the impact of the 1973 Yom Kippur War upon NATO thinking about warning and surprise in the mid-1970s. It concludes that the arrangements made by Whitehall for support to BAOR from national assets during crisis or transition to war were - at best - improbable. Accordingly, over the years, BAOR developed its own unique assets in the realm of both intelligence collection and special operations in order to prepare for the possible outbreak of conflict

    Large infrapatellar ganglionic cyst of the knee fat pad: a case report and review of the literature

    Get PDF
    <p>Abstract</p> <p>Introduction</p> <p>Large ganglionic cystic formations arising from the infrapatellar fat pad are quite uncommon and only a few are mentioned in the literature. An open excision in these cases is mandatory.</p> <p>Case presentation</p> <p>We report the case of a large infrapatellar fat pad ganglion in a 37-year-old Greek man with chronic knee discomfort. The ganglionic cyst originated from the infrapatellar fat pad and had no intrasynovial extension. The final diagnosis was determined with magnetic resonance imaging of the knee, and the lesion was treated with surgery.</p> <p>Conclusions</p> <p>These lesions are asymptomatic in most cases but often are misdiagnosed as meniscal or ligamentous lesions of the knee joint. Nowadays, the therapeutic trend for such lesions is arthroscopic excision, but when there is a large ganglion, as in this case report, the treatment should be an open and thorough resection. This report is intended mostly but not exclusively for clinical physicians and radiologists.</p

    Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.

    Get PDF
    BackgroundThe SCID-hu Thy/Liv mouse model of HIV-1 infection is a useful platform for the preclinical evaluation of antiviral efficacy in vivo. We performed this study to validate the model with representatives of all four classes of licensed antiretrovirals.Methodology/principal findingsEndpoint analyses for quantification of Thy/Liv implant viral load included ELISA for cell-associated p24, branched DNA assay for HIV-1 RNA, and detection of infected thymocytes by intracellular staining for Gag-p24. Antiviral protection from HIV-1-mediated thymocyte depletion was assessed by multicolor flow cytometric analysis of thymocyte subpopulations based on surface expression of CD3, CD4, and CD8. These mice can be productively infected with molecular clones of HIV-1 (e.g., the X4 clone NL4-3) as well as with primary R5 and R5X4 isolates. To determine whether results in this model are concordant with those found in humans, we performed direct comparisons of two drugs in the same class, each of which has known potency and dosing levels in humans. Here we show that second-generation antiretrovirals were, as expected, more potent than their first-generation predecessors: emtricitabine was more potent than lamivudine, efavirenz was more potent than nevirapine, and atazanavir was more potent than indinavir. After interspecies pharmacodynamic scaling, the dose ranges found to inhibit viral replication in the SCID-hu Thy/Liv mouse were similar to those used in humans. Moreover, HIV-1 replication in these mice was genetically stable; treatment of the mice with lamivudine did not result in the M184V substitution in reverse transcriptase, and the multidrug-resistant NY index case HIV-1 retained its drug-resistance substitutions.ConclusionGiven the fidelity of such comparisons, we conclude that this highly reproducible mouse model is likely to predict clinical antiviral efficacy in humans

    Overcoming blame culture: key strategies to catalyse maternal and perinatal death surveillance and response.

    Get PDF
    Maternal and perinatal death surveillance and response (MPDSR) is a health systems process entailing the continuous cycle of identification, notification, and review of maternal and perinatal deaths (Surveillance), followed by actions to improve service delivery and quality of care and Response. Prior to the COVID-19 pandemic, there were an estimated 4.6 million maternal and newborn deaths and stillbirths each year. During the pandemic, maternal and perinatal health outcomes have worsened, especially in low- and middle-income countries, highlighting the urgent need to galvanize MPDSR to end preventable mortality and strengthen health systems

    Measurement of the branching fraction and CP content for the decay B(0) -> D(*+)D(*-)

    Get PDF
    This is the pre-print version of the Article. The official published version can be accessed from the links below. Copyright @ 2002 APS.We report a measurement of the branching fraction of the decay B0→D*+D*- and of the CP-odd component of its final state using the BABAR detector. With data corresponding to an integrated luminosity of 20.4  fb-1 collected at the Υ(4S) resonance during 1999–2000, we have reconstructed 38 candidate signal events in the mode B0→D*+D*- with an estimated background of 6.2±0.5 events. From these events, we determine the branching fraction to be B(B0→D*+D*-)=[8.3±1.6(stat)±1.2(syst)]×10-4. The measured CP-odd fraction of the final state is 0.22±0.18(stat)±0.03(syst).This work is supported by DOE and NSF (USA), NSERC (Canada), IHEP (China), CEA and CNRS-IN2P3 (France), BMBF (Germany), INFN (Italy), NFR (Norway), MIST (Russia), and PPARC (United Kingdom). Individuals have received support from the A.P. Sloan Foundation, Research Corporation, and Alexander von Humboldt Foundation
    corecore